| Plasma exosome microRNAs are indicative of breast cancer BN Hannafon, YD Trigoso, CL Calloway, YD Zhao, DH Lum, AL Welm, ... Breast cancer research 18, 1-14, 2016 | 550 | 2016 |
| Intercellular communication by exosome-derived microRNAs in cancer BN Hannafon, WQ Ding International journal of molecular sciences 14 (7), 14240-14269, 2013 | 542 | 2013 |
| Chloroquine is a zinc ionophore J Xue, A Moyer, B Peng, J Wu, BN Hannafon, WQ Ding PloS one 9 (10), e109180, 2014 | 301 | 2014 |
| Anticancer activity of the antibiotic clioquinol WQ Ding, B Liu, JL Vaught, H Yamauchi, SE Lind Cancer research 65 (8), 3389-3395, 2005 | 295 | 2005 |
| Exosome-mediated microRNA signaling from breast cancer cells is altered by the anti-angiogenesis agent docosahexaenoic acid (DHA) BN Hannafon, KJ Carpenter, WL Berry, R Janknecht, WC Dooley, ... Molecular cancer 14, 1-13, 2015 | 231 | 2015 |
| MicroRNA-19 (miR-19) regulates tissue factor expression in breast cancer cells X Zhang, H Yu, JR Lou, J Zheng, H Zhu, NI Popescu, F Lupu, SE Lind, ... Journal of biological chemistry 286 (2), 1429-1435, 2011 | 170 | 2011 |
| Nitroxoline (8-hydroxy-5-nitroquinoline) is more a potent anti-cancer agent than clioquinol (5-chloro-7-iodo-8-quinoline) H Jiang, JE Taggart, X Zhang, DM Benbrook, SE Lind, WQ Ding Cancer letters 312 (1), 11-17, 2011 | 166 | 2011 |
| Plasma exosome miR-196a and miR-1246 are potential indicators of localized pancreatic cancer YF Xu, BN Hannafon, YD Zhao, RG Postier, WQ Ding Oncotarget 8 (44), 77028, 2017 | 163 | 2017 |
| Metal ionophores–an emerging class of anticancer drugs WQ Ding, SE Lind IUBMB life 61 (11), 1013-1018, 2009 | 163 | 2009 |
| Clioquinol targets zinc to lysosomes in human cancer cells H Yu, Y Zhou, SE Lind, WQ Ding Biochemical journal 417 (1), 133-139, 2009 | 127 | 2009 |
| Differential sensitivity of cancer cells to docosahexaenoic acid–induced cytotoxicity: The potential importance of down-regulation of superoxide dismutase 1 expression WQ Ding, JL Vaught, H Yamauchi, SE Lind Molecular cancer therapeutics 3 (9), 1109-1117, 2004 | 111 | 2004 |
| A misspliced form of the cholecystokinin-B/gastrin receptor in pancreatic carcinoma: role of reduced cellular U2AF35 and a suboptimal 3′-splicing site leading to retention of … WQ Ding, SM Kuntz, LJ Miller Cancer research 62 (3), 947-952, 2002 | 103 | 2002 |
| Disulfiram's anticancer activity: evidence and mechanisms Y Jiao, B N Hannafon, WQ Ding Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2016 | 101 | 2016 |
| miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study BN Hannafon, A Cai, CL Calloway, YF Xu, R Zhang, KM Fung, WQ Ding BMC cancer 19, 1-12, 2019 | 98 | 2019 |
| Activation of peroxisome proliferator-activated receptor α (PPARα) suppresses hypoxia-inducible factor-1α (HIF-1α) signaling in cancer cells J Zhou, S Zhang, J Xue, J Avery, J Wu, SE Lind, WQ Ding Journal of Biological Chemistry 287 (42), 35161-35169, 2012 | 83 | 2012 |
| Clioquinol and docosahexaenoic acid act synergistically to kill tumor cells WQ Ding, B Liu, JL Vaught, RD Palmiter, SE Lind Molecular cancer therapeutics 5 (7), 1864-1872, 2006 | 82 | 2006 |
| The Nrf2/GCH1/BH4 axis ameliorates radiation-induced skin injury by modulating the ROS cascade J Xue, C Yu, W Sheng, W Zhu, J Luo, Q Zhang, H Yang, H Cao, W Wang, ... Journal of Investigative Dermatology 137 (10), 2059-2068, 2017 | 74 | 2017 |
| Silencing of secretin receptor function by dimerization with a misspliced variant secretin receptor in ductal pancreatic adenocarcinoma WQ Ding, ZJ Cheng, J McElhiney, SM Kuntz, LJ Miller Cancer research 62 (18), 5223-5229, 2002 | 74 | 2002 |
| HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy M Mehta, K Basalingappa, JN Griffith, D Andrade, A Babu, N Amreddy, ... Oncotarget 7 (40), 64820, 2016 | 72 | 2016 |
| Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma … Q Gu, Y He, J Ji, Y Yao, W Shen, J Luo, W Zhu, H Cao, Y Geng, J Xu, ... Oncotarget 6 (13), 10893, 2015 | 67 | 2015 |
